Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 4Completed 4Active not recruiting 2

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 1324Neoplasms 982Carcinoma, Non-Small-Cell Lung 860Prostatic Neoplasms 724Colorectal Neoplasms 666Lung Neoplasms 551Leukemia, Myeloid, Acute 475Neoplasm Metastasis 434Pancreatic Neoplasms 419Carcinoma, Hepatocellular 407Multiple Myeloma 396Ovarian Neoplasms 392Stomach Neoplasms 379Recurrence 364Squamous Cell Carcinoma of Head and Neck 325Melanoma 294Brain Neoplasms 287Uterine Cervical Neoplasms 283Triple Negative Breast Neoplasms 271Glioblastoma 264Head and Neck Neoplasms 263Precursor Cell Lymphoblastic Leukemia-Lymphoma 254Endometrial Neoplasms 234Lymphoma 228Rectal Neoplasms 222Esophageal Neoplasms 222Sarcoma 213Carcinoma, Renal Cell 203Colonic Neoplasms 194Lymphoma, Non-Hodgkin 191

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Interventional × Solid Malignancies × Clear all
NCT06725381 2026-05-08

A Phase 1 Study of SKB571 in Subjects With Advanced Solid Tumors

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 1 Recruiting
138 enrolled

Solid Malignancies

NCT07505771 2026-04-06

A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

Immunome, Inc.

Phase EARLY_PHASE1 Recruiting
105 enrolled

Solid Malignancies

NCT06600789 2025-11-03

A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

Carrick Therapeutics Limited

Phase 1/2 Recruiting
50 enrolled

Solid Malignancies

NCT06933069 2025-09-11

Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors

Taizhou Mabtech Pharmaceutical Co.,Ltd

Phase 1 Recruiting
55 enrolled

Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡